1. Home
  2. PGEN vs CPZ Comparison

PGEN vs CPZ Comparison

Compare PGEN & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • CPZ
  • Stock Information
  • Founded
  • PGEN 1998
  • CPZ 2019
  • Country
  • PGEN United States
  • CPZ United States
  • Employees
  • PGEN N/A
  • CPZ N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • CPZ Trusts Except Educational Religious and Charitable
  • Sector
  • PGEN Health Care
  • CPZ Finance
  • Exchange
  • PGEN Nasdaq
  • CPZ Nasdaq
  • Market Cap
  • PGEN 292.6M
  • CPZ 305.7M
  • IPO Year
  • PGEN N/A
  • CPZ N/A
  • Fundamental
  • Price
  • PGEN $0.75
  • CPZ $15.60
  • Analyst Decision
  • PGEN Buy
  • CPZ
  • Analyst Count
  • PGEN 5
  • CPZ 0
  • Target Price
  • PGEN $7.00
  • CPZ N/A
  • AVG Volume (30 Days)
  • PGEN 880.4K
  • CPZ 63.0K
  • Earning Date
  • PGEN 11-14-2024
  • CPZ 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • CPZ 11.07%
  • EPS Growth
  • PGEN N/A
  • CPZ N/A
  • EPS
  • PGEN N/A
  • CPZ N/A
  • Revenue
  • PGEN $3,963,000.00
  • CPZ N/A
  • Revenue This Year
  • PGEN N/A
  • CPZ N/A
  • Revenue Next Year
  • PGEN $426.76
  • CPZ N/A
  • P/E Ratio
  • PGEN N/A
  • CPZ N/A
  • Revenue Growth
  • PGEN N/A
  • CPZ N/A
  • 52 Week Low
  • PGEN $0.75
  • CPZ $13.17
  • 52 Week High
  • PGEN $1.93
  • CPZ $16.11
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 37.82
  • CPZ 51.44
  • Support Level
  • PGEN $0.76
  • CPZ $15.35
  • Resistance Level
  • PGEN $0.83
  • CPZ $15.68
  • Average True Range (ATR)
  • PGEN 0.06
  • CPZ 0.21
  • MACD
  • PGEN -0.01
  • CPZ -0.00
  • Stochastic Oscillator
  • PGEN 0.09
  • CPZ 53.09

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.

Share on Social Networks: